JCPSLP Vol 18 No. 1Mar 2016

15 / 100

JCPSLP Volume 18, Number 1 2016 14
AlexandraCallinsisaspeechpathologistworkinginaBrisbane
private practice. Annie Hill is a research fellow in the CRE
TelehealthattheUniversityofQueensland,Brisbane.Deborah
TheodorosisaProfessorofspeechpathologyattheUniversityof
Queensland, Brisbane.
Correspondence to:
Dr Annie Hill,
School of Health and Rehabilitation Sciences
University of Queensland
email:
and Hearing Research, 38(6), 1232–1251. doi:10.1044/
jshr.3806.1232
Ramig, L. O., Sapir, S., Countryman, S., Pawlas,
A. A., O’Brien, C., Hoehn, M., & Thompson, L. L.
(2001). Intensive voice treatment (LSVT) for patients
with Parkinson’s disease: A 2 year follow up. Journal of
Neurology, Neurosurgery, and Psychiatry, 71(4), 493–498.
doi:10.1136/jnnp.71.4.493
Ramig, L. O., Sapir, S., Fox, C., & Countryman, S.
(2001). Changes in vocal loudness following intensive
voice treatment (LSVT®) in individuals with Parkinson’s
disease: A comparison with untreated patients and normal
age-matched controls. Movement Disorders, 16(1),
79–83. doi:10.1002/1531-8257(200101)16:1<79::AID-
MDS1013 ;2-H
Sanderson, K. B., Roditi, D., George, S. Z., Atchison,
J. W., Banou, E., & Robinson, M. E. (2012). Investigating
patient expectations and treatment outcome in a chronic
low back pain population. Journal of Pain Research, 5,
15–22. doi:10.2147/JPR.S28636
Smeets, R. J., Beelen, S., Goossens, M. E., Schouten,
E. G., Knottnerus, J. A., & Vlaeyen, J. W. (2008). Treatment
expectancy and credibility are associated with the outcome
of both physical and cognitive-behavioral treatment in
chronic low back pain. Clinical Journal of Pain, 24(4),
305–315. doi:10.1097/AJP.0b013e318164aa75
Spielman, J. L., Borod, J. C., & Ramig, L. O. (2003). The
effects of intensive voice treatment on facial expressiveness
in Parkinson disease: Preliminary data. Cognitive and
Behavioral Neurology: Official Journal of the Society for
Behavioral and Cognitive Neurology, 16(3), 177–188.
doi:10.1097/00146965–200309000–00005
Taylor, T. H. (2010). Ceiling effect. Encyclopedia of
research design. Thousand Oaks, CA: Sage Publications.
Trail, M., Fox, C., Ramig, L. O., Sapir, S., Howard, J., &
Lai, E. C. (2005). Speech treatment for Parkinson’s disease.
NeuroRehabilitation, 20(3), 205-221.
Tung, Y. C., Cooke, M., & Moyle, W. (2013). A theoretical
model of efficacy beliefs, functional status and quality of
life for older people during rehabilitation: Testing causal
relationships. Journal of Advanced Nursing, 69(9), 2008–
2019. doi:10.1111/jan.12063
van der Hoek, T. C., Bus, B. A. A., Matui, P., van der
Marck, M. A., Esselink, R. A., & Tendolkar, I. (2011).
Prevalence of depression in Parkinson’s disease: Effects of
disease stage, motor subtype and gender. Journal of the
Neurological Sciences, 310, 220–224.
Walshe, M., Peach, R., & Miller, N. (2009). Dysarthria
Impact Profile: Development of a scale to measure
psychosocial effects. International Journal of Language
& Communication Disorders, 44(5), 693–715.
doi:10.1080/13682820802317536
Ward, E. C., Theodoros, D. G., Murdoch, B. E., &
Silburn, P. (2000). Changes in maximum capacity tongue
function following the Lee Silverman Voice Treatment
Program. Journal of Medical Speech-Language Pathology,
8(4), 331–335.
Wight, S., & Miller, N. (2015). Lee Silverman Voice
Treatment for people with Parkinson’s: Audit of outcomes
in a routine clinic. International Journal of Language and
Communication Disorders, 50 (2), 215–225.